cantar 16 mg tabletes
teva pharma b.v., netherlands - kandesartāna cileksetils - tablete - 16 mg
perindopril teva 10 mg apvalkotās tabletes
teva pharma b.v., netherlands - perindoprila tosilāts - apvalkotās tabletes - 10 mg
quinapril/hct teva 10 mg/12,5 mg apvalkotās tabletes
teva pharma b.v., netherlands - quinaprilum, hydrochlorothiazidum - apvalkotās tabletes - 10 mg/12,5 mg
klatex 500 mg ilgstošās darbības tabletes
teva pharma b.v., netherlands - klaritromicīns - ilgstošās darbības tabletes - 500 mg
perindopril teva 5 mg apvalkotās tabletes
teva pharma b.v., netherlands - perindoprila tosilāts - apvalkotās tabletes - 5 mg
ghryvelin (previously macimorelin aeterna zentaris)
atnahs pharma netherlands b.v. - macimorelin acetāts - diagnostikas metodes, endokrīnās - macimorelīns - Šīs zāles ir paredzētas tikai diagnostikas vajadzībām. ghryvelin is indicated for the diagnosis of growth hormone deficiency (ghd) in adults.
silodosin recordati
recordati ireland ltd - silodosin - prostatas hiperplāzija - urologicals, alfa-adrenoreceptor antagonistiem - Ārstēšanu, simptomi un pazīmes, labdabīgas prostatas hiperplāzijas (bph) pieauguši vīrieši.
libtayo
regeneron ireland designated activity company (dac) - cemiplimab - karcinoma, švamšā šūna - antineoplastiski līdzekļi - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.
ultravit supplements vitamin d3 (2019.) kapsula
ražots Ķīnā pēc vp laboratory ltd. the south quay building 189 marsh wall, london, e14 9sh, uk pasūtījuma - kapsula
equazen® baby (paziņots 2011.) kapsula
vifor pharma uk ltd. - kapsula